Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
64
Number of overlapping holdings
100.0%
% of XLV's 65 holdings also in VHT
16.1%
% of VHT's 413 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus VHT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in VHT |
Overlap | |
|---|---|---|---|---|
 |
UNITEDHEALTH GROUP INC | 9.3% | 8.1% | 8.1% |
|
JOHNSON & JOHNSON | 8.4% | 7.3% | 7.3% |
|
ABBVIE INC | 5.8% | 5.0% | 5.0% |
|
ELI LILLY & CO | 5.5% | 4.9% | 4.9% |
|
MERCK & CO. INC. | 5.6% | 4.9% | 4.9% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to VHT
|
UNITEDHEALTH GROUP INC | 1.2% |
|
JOHNSON & JOHNSON | 1.1% |
|
ABBVIE INC | 0.7% |
|
MERCK & CO. INC. | 0.7% |
|
PFIZER INC | 0.6% |
|
ELI LILLY & CO | 0.6% |
|
THERMO FISHER SCIENTIFIC INC | 0.6% |
|
ABBOTT LABORATORIES | 0.5% |
|
BRISTOL-MYERS SQUIBB CO | 0.4% |
|
GILEAD SCIENCES INC | 0.3% |
XLV Underweight Relative to VHT
|
SEATTLE GENETICS INC | -0.5% |
|
VEEVA SYSTEMS INC-CLASS A | -0.4% |
|
HORIZON PHARMA PLC | -0.4% |
|
ALNYLAM PHARMACEUTICALS INC | -0.4% |
|
BIOMARIN PHARMACEUTICAL INC | -0.3% |
|
AVANTOR, INC. | -0.3% |
|
ROYALTY PHARMA PLC CLASS A | -0.2% |
|
EXACT SCIENCES CORP | -0.2% |
|
UNITED THERAPEUTICS CORP | -0.2% |
|
SAREPTA THERAPEUTICS INC | -0.2% |